| Literature DB >> 27477687 |
Niek G J Leus1, Birgit Honrath2, Nikolaos Eleftheriadis1, Hessel Poelman1, Constantinos G Neochoritis3, Amalia Dolga4, Alexander Dömling3, Frank J Dekker1.
Abstract
The enzyme 15-lipoxygenase-1 (15-LOX-1) plays a dual role in diseases with an inflammatory component. On one hand 15-LOX-1 plays a role in pro-inflammatory gene expression and on the other hand it has been shown to be involved in central nervous system (CNS) disorders by its ability to mediate oxidative stress and damage of mitochondrial membranes under hypoxic conditions. In order to further explore applications in the CNS, novel 15-LOX-1 inhibitors with favorable physicochemical properties need to be developed. Here, we present Substitution Oriented Screening (SOS) in combination with Multi Component Chemistry (MCR) as an effective strategy to identify a diversely substituted small heterocyclic inhibitors for 15-LOX-1, denoted ThioLox, with physicochemical properties superior to previously identified inhibitors. Ex vivo biological evaluation in precision-cut lung slices (PCLS) showed inhibition of pro-inflammatory gene expression and in vitro studies on neuronal HT-22 cells showed a strong protection against glutamate toxicity for this 15-LOX-1 inhibitor. This provides a novel approach to identify novel small with favorable physicochemical properties for exploring 15-LOX-1 as a drug target in inflammatory diseases and neurodegeneration.Entities:
Keywords: 15-Lipoxygenase; Inflammation; Multi component chemistry; Neurodegeneration; Substitution Oriented Screening; Thiophene-based inhibitor
Mesh:
Substances:
Year: 2016 PMID: 27477687 PMCID: PMC5010146 DOI: 10.1016/j.ejmech.2016.07.010
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514